The present studies were undertaken to examine the expression of the high density lipoprotein (HDL) receptor, SR-B1 messenger RNA (mRNA) in ovarian cell types during folliculogenesis and luteinization using in situ hybridization histochemistry and to examine its hormonal regulation using Northern blots. For the in situ study for HDL receptor mRNA localization, 21-day-old rats were treated with 50 IU PMSG, and ovaries were collected 0, 24, and 56 h postinjection. At 56 h, animals were treated with a single dose of hCG, and ovaries were subsequently collected at 6-, 12-, 24-, and 72-h and 5-day intervals. In addition, on day 4 of pseudopregnancy, a second dose of 50 IU hCG or saline was administered, and ovaries were collected at 12, 24, and 48 h to determine the induction of the expression of HDL receptor mRNA. The results of in situ hybridization histochemistry showed that in the immature ovary, HDL receptor mRNA is associated with theca interna and interstitial cells (stroma). The mRNA expression in these cell types increased with PMSG treatment, but no signal was detected in the granulosa cells. Northern blot analysis also showed a marked increase in mRNA content in thecal and interstitial cells during follicular development. During luteinization, the intensity of the signal began to appear in the luteinized granulosa cells. With the completion of luteinization, the signal in the corpus luteum tissue became more intense. Further treatment with hCG increased the HDL receptor mRNA content compared with that in the salinetreated control. These results demonstrate that the cholesterol-using cell types of the ovary, namely the interstitial cells, thecal cells, and fully luteinized granulosa cells are endowed with the HDL receptor mRNA, which provides credence to the functional significance of the role of HDL receptor SR-B1 in cholesterol transport and ovarian steroidogenesis. (Endocrinology 139: 3043-3049, 1998) P LASMA lipoproteins are the major source of cholesterol for steroidogenesis by the rat ovarian tissues (1, 2). The uptake of low density lipoprotein (LDL)-derived cholesterol involves specific binding of the LDL particles to cell surface receptors followed by internalization of the LDL particles and lysosomal hydrolysis to release cholesterol esters, as described by Brown and Goldstein (3). However, utilization of the high density lipoprotein (HDL)-derived cholesterol is not understood to the same degree as is utilization of LDL cholesterol. Receptors for LDL and HDL have been characterized in the membrane fractions obtained from ovarian tissues (4 -8). Specific binding of HDL fractions to high affinity receptors has been demonstrated in other systems as well (9, 10). Two reports have appeared in the literature that describe the cloning of putative HDL receptors (11, 12) . Recently, it has been suggested that the scavenger receptor class B type 1, SR-B1, a previously identified protein that specifically recognizes acetylated LDL particles, is capable of recognizing HDL particles and therefore functions as the HDL receptor (13-15). The scavenger receptor SR-B1 was expression cloned from a Chinese hamster ovary (CHO) cell variant and was shown to be a member of CD36 family of membrane proteins (13). Like CD36, the scavenger receptor SR-B1 exhibits high affinity binding for acetylated LDL (13).
P
LASMA lipoproteins are the major source of cholesterol for steroidogenesis by the rat ovarian tissues (1, 2) . The uptake of low density lipoprotein (LDL)-derived cholesterol involves specific binding of the LDL particles to cell surface receptors followed by internalization of the LDL particles and lysosomal hydrolysis to release cholesterol esters, as described by Brown and Goldstein (3) . However, utilization of the high density lipoprotein (HDL)-derived cholesterol is not understood to the same degree as is utilization of LDL cholesterol. Receptors for LDL and HDL have been characterized in the membrane fractions obtained from ovarian tissues (4 -8) . Specific binding of HDL fractions to high affinity receptors has been demonstrated in other systems as well (9, 10) . Two reports have appeared in the literature that describe the cloning of putative HDL receptors (11, 12) . Recently, it has been suggested that the scavenger receptor class B type 1, SR-B1, a previously identified protein that specifically recognizes acetylated LDL particles, is capable of recognizing HDL particles and therefore functions as the HDL receptor (13) (14) (15) . The scavenger receptor SR-B1 was expression cloned from a Chinese hamster ovary (CHO) cell variant and was shown to be a member of CD36 family of membrane proteins (13) . Like CD36, the scavenger receptor SR-B1 exhibits high affinity binding for acetylated LDL (13) .
Previous studies from our laboratory have established the presence of a scavenger receptor in the rat luteal cells that specifically binds acetylated LDL with high affinity and have shown that this receptor is distinct from the LDL receptor (16) . Additionally, we showed that the rat luteal cells use acetylated LDL for progesterone production (16) . Although acetylated LDL was capable of supplying cholesterol for steroid synthesis in the luteal tissue, its physiological significance was not understood, as acetylated LDL is not a naturally occurring ligand. As it appears that the scavenger receptor SR-B1 might be the HDL receptor, the present studies were undertaken to examine its physiological role in ovarian tissue during follicular development and corpus luteum formation. Specifically, we have examined the expression of SR-B1 messenger RNA (mRNA) in ovarian tissue using in situ hybridization histochemistry. Our results show that SR-B1 mRNA is expressed in steroidogenic ovarian cells in a manner consistent with their use of exogenous cholesterol for steroid hormone production.
Materials and Methods Animals
Immature 21-day-old Sprague-Dawley female rats (Harlan Farms, Indianapolis, IN) were injected sc with 50 IU PMSG (Calbiochem, La Jolla, CA), followed by 25 IU hCG (supplied by the Center for Population Research, NIH, and NIAMDD) 56 h later to induce superovulation and subsequent luteinization (17) . When indicated, pseudopregnant animals were treated with 50 IU hCG on day 4 of pseudopregnancy; control rats received an equal volume of saline. Ovaries were collected at specific time periods, frozen in liquid nitrogen, and stored until use at Ϫ80 C.
In situ hybridization
Ovaries frozen in OCT compound (Miles, Elkhart, IN) were cut at Ϫ20 C using a Reichert 2800 Frigocut-N cryostat (Leica, Deerfield, IL), and 10-m sections were mounted on silane-coated slides. Tissue sections were fixed in 4% paraformaldehyde (pH 7.4) for 1 h, washed in PBS for 15 min, incubated with proteinase K (1 g/ml) for 10 min at 37 C, and rinsed with distilled deionized water. Subsequently, slides were placed in 0.1 m triethanolamine (pH 8.0), and after the addition of acetic anhydride (final concentration, 0.25%, vol/vol), they were incubated for 10 min. Sections were then washed with 2 ϫ SSC (SSC ϭ 0. 15 (18) . The SR-B1 probe was amplified from the SR-B1 cDNA sequence corresponding to nucleotides 170 -477 by PCR cloning (14) . The RNA probe [1-3 ϫ 10 7 cpm/ml in hybridization buffer (75% formamide, 3 ϫ SSC, 1 ϫ Denhardt's reagent [0.02% BSA, 0.02% Ficoll, and 0.02% polyvinylpyrrolidone], 0.05 m sodium phosphate (pH 7.4), 10% dextran sulfate, 1 mm dithiothreitol, and 200 g/ml yeast transfer RNA)] was applied to the tissue sections, coverslips were overlaid and sealed with rubber cement, and slides were incubated at 55 C overnight in a moist chamber, as previously described (19) . After hybridization, sections were washed in 2 ϫ SSC, treated with ribonuclease A (200 g/ml) and ribonuclease T1 (4 U/ml) at 37 C for 1 h, and washed in increasingly lower concentrations of SSC (2 to 0.2 ϫ). After a final incubation in 0.1 ϫ SSC-0.1% SDS for 1 h at 55 C, sections were dehydrated through graded alcohols (50 -100%) and dried. The slides were processed for liquid emulsion autoradiography using NTB-2 emulsion (Eastman Kodak, Rochester, NY). Slides were developed after 2-5 days and counterstained with hematoxylin-eosin.
Northern analysis
Total RNA was extracted from tissues using the procedures of Chomczynski and Sacchi (20) . Tissues were homogenized in a solution of guanidine isothiocyanate, acidified with 2 m sodium acetate (pH 4.0), and extracted with water-saturated phenol and chloroform-isoamyl alcohol (49:1). RNA remaining in the aqueous phase was precipitated overnight at 20 C using 3 vol ethanol. RNA was spectrophotometrically FIG. 1. SR-B1 mRNA levels during follicular development. Total RNA was extracted from ovaries collected 0, 28, and 56 h after PMSG injection, and Northern blot analysis was performed using radiolabeled SR-B1 cDNA probe (A). Radiolabeled cDNA for 18S ribosomal RNA was used to monitor loading. Densitometric units corresponding to SR-B1 mRNA are expressed relative to the 18S ribosomal RNA signal at each time interval (B). The results presented are representative of one of three experiments.
FIG. 2.
In situ hybridization of SR-B1 mRNA during follicular development: 0 h. Ovaries were collected from immature (21-day-old) rats. Tissue sections were hybridized with antisense SR-B1 probe and photographed at ϫ15 magnification using darkfield optics to show hybridization (A) and brightfield optics to show structures (B).
quantified, and its purity was determined by the A 260 /A 280 ratio. Aliquots of total RNA were separated by electrophoresis in 1.2% agaroseformaldehyde gels and transferred to nitrocellulose membranes using 10 ϫ SSC. Blots were UV cross-linked and prehybridized at 42 C for 2 h in a solution containing salmon sperm DNA (0.5 mg/ml) and 2 ϫ hybridization buffer [1.5 NaCl and 0.1 TES (N-Tris[hydroxy-methyl]-methyl-2-aminoethanesulfonic acid, pH 7.1; 0.1 m EDTA; and 2 ϫ Denhardt's solution] diluted 1:1 with deionized formamide. An SR-B1 cDNA probe (308 bp) was radiolabeled using [␣-32 P]deoxy-CTP (ICN, Irvine, CA) and the Klenow fragment of DNA polymerase, and hybridized to blots overnight at 42 C in fresh hybridization buffer using 2 ϫ 10 7 cpm labeled probe. Hybridized blots were washed four times with 2 ϫ SSC containing 0.1% SDS for 10 min each time at room temperature and once at 60 C for 30 min. The washed blots were exposed overnight at Ϫ70 C to Kodak XAR film in a cassette containing intensifying screens. The film was developed, and the signals were measured using a Zeineh (Fullerton, CA) soft laser scanning densitometer (model SL-TRFF). After stripping the blots, they were rehybridized to a cDNA probe corresponding to 18S ribosomal RNA radiolabeled with [␣-32 P]deoxy CTP as described above to normalize for RNA in the Northern blots.
Results

SR-B1 expression during follicular development
The expression of SR-B1 mRNA during rat ovarian follicular development is shown in Fig. 1 . Twenty-one-day-old rats were treated with 50 IU PMSG, and the ovaries were collected at 0, 28, and 56 h of treatment. RNA was extracted, and Northern blots were performed using 308 bp SR-B1 cDNA probe. The blots of the SR-B1 mRNA and the hybridization signal of the 18S RNA are shown in To analyze cell-specific expression of the SR-B1 mRNA, in situ hybridization studies were carried out using ovaries collected at 0, 24, and 56 h of PMSG treatment. The hybridization of the 35 S-labeled antisense SR-B1 RNA probe to tissue sections is shown in Fig. 2 . Figure 2A shows the darkfield photomicrographs of the SR-B1 probe hybridized to tissues collected at the initiation of hormone treatment. Hybridization was restricted to interstitial cells (stroma) and theca interna, but the hybridization signal was absent in the granulosa cells. The corresponding brightfield photograph of the hematoxylin-stained section is shown in Fig. 2B , which clearly shows numerous follicles with surrounding thecal cells and the granulosa cells in the follicles. The intensity of the hybridization signal in theca interna and stroma was higher in tissues collected 24 h after PMSG treatment (Fig.  3A) . Granulosa cells showed no hybridization signal. The number of healthy follicles showed an increase by 24 h of hormone treatment, as evidenced by the appearance of the follicles in the brightfield photomicrographs (Fig. 3B) , and these follicles exhibited an increase in the intensity of the hybridization signal specifically confined to theca interna and stroma. At 56 h, the intensity of the hybridization signal in theca interna and stroma was further increased (Fig. 4A) . The corresponding brightfield photomicrographs showed a number of well developed follicles (Fig. 4B) .
SR-B1 expression in corpus luteum
The expression of SR-B1 mRNA was then examined in the ovarian tissue during luteinization of the PMSG-treated rats. At 56 h after PMSG treatment, the rats were treated with 25 IU hCG. The ovaries were collected 6, 12, 24, 72, and 120 h after hCG treatment, and the in situ hybridization of antisense SR-B1 RNA probe to tissue sections was determined.
The darkfield photomicrograph of the in situ hybridization of the 35 S-labeled antisense SR-B1 RNA 6 h after hCG administration is shown in Fig. 5A , and the corresponding brightfield photomicrograph is shown in Fig. 5B . The intensity of hybridization to the thecal cells was further increased, but the hybridization to granulosa cells was only beginning to develop, as luteinization of the granulosa cells was only minimal at this time. At 12 h, the hybridization signal in the granulosa cells was not markedly increased. The hybridization signal was also detectable in follicles that were not fully developed; surrounding layers of theca also responded to hCG treatment (Fig. 6, A and B) . As the corpus luteum was fully developed, the luteinized granulosa cells showed significant hybridization signal as shown in Fig. 7 . By 72 h, the predominant cell types, which showed high intensity hybridization signal, were primarily the luteal cells in corpora lutea, with significantly less hybridizable SR-B1 mRNA in the other existing ovarian structures, such as regressing follicles and stromal cells (Fig. 8, A and B) . By day 5, the hybridization signal showed dramatic increases (Fig. 9A) in the corpora lutea. At this time, the ovary exhibited the presence of a number of well developed corpora lutea (Fig. 9B) . Thus, the expression of SR-B1 shows good correlation with the steroidogenic potential of the corpora lutea. No appreciable hybridization signal was detected when the tissue sections (120 h after hCG treatment) were hybridized with a 308-bp SR-B1 sense RNA, showing the specificity of the hybridization reaction (Fig. 10) .
Induction of SR-B1 mRNA expression by hCG
The regulation of SR-B1 mRNA in the corpus luteum was examined by instituting hCG administration on day 4 of pseudopregnancy. Figure 11 shows the effect of hCG administration on SR-B1 mRNA expression on day 4 after cor- pus luteum formation using PMSG-hCG regimen. The expression of SR-B1 mRNA was markedly higher in response to hormone treatment than that in the corresponding salinetreated controls. It should be pointed out that the relative intensity of the SR-B1 mRNA in the control is lower than would be expected on day 4 of pseudopregnancy on the basis of in situ hybridization signal (Figs. 8A and 9A ). As the hCG-treated group exhibited high levels of SR-B1 mRNA expression, the blots were exposed for only a short period to quantify the signal. From these studies we conclude that SR-B1 mRNA expression in the corpus luteum is induced by hCG administration.
Discussion
The present study is an extension of our previous report in which we showed the existence of the scavenger receptor that recognized acetylated LDL (16) . This was the first report demonstrating the existence of the scavenger receptor in the ovary. Recently, Acton et al. (14) presented the intriguing possibility that the previously cloned scavenger receptor, class B, type I (SR-B1) in fact functions as a HDL receptor. Furthermore, the widespread distribution of SR-B1, particularly in the steroidogenic tissues, including the adrenal cortex, testes, and ovary, supports a physiological role for this receptor (21) . Its expression has been shown in rat ovarian tissue, and the receptor in the rat ovary shows significant homology to that previously cloned (22) .
To determine whether SR-B1 is expressed in cell types that use HDL-derived cholesterol for steroidogenesis, we used in situ hybridization histochemistry to identify SR-B1 mRNA expression in various ovarian cell types during folliculogenesis, corpus luteum formation, and the life span of the corpus luteum. The ovary is a dynamic structure and undergoes marked changes during the reproductive cycle (23) . During the early phase of follicle maturation, the major steroidogenic cell types are the interstitial and thecal cells, both of which convert cholesterol to steroid hormones. The principal secretory products at this stage of the ovarian cycle are the androgens (24) . The granulosa cells become active in steroid synthesis during follicle maturation; these cells convert androgens produced by the theca-interstitial cells to estrogens (25) . After ovulation, the granulosa cells undergo differentiation, resulting in the formation of luteal cells, which have the ability to convert cholesterol to steroid hormones. Thus, if SR-B1 is physiologically significant in cholesterol transport into the ovary for steroid hormone biosynthesis, it is expected that its expression will be detectable in cell types that use cholesterol for steroid production.
Our results show that the SR-B1 is minimally expressed at the onset of follicle development. At this stage, the ovary contains numerous primordial follicles and interstitial cells and layers of thecal cells. The major steroidogenic products at this stage of follicular growth are progesterone, androst-4-ene-3,17-dione, testosterone, and their metabolites (24) . It is interesting to note that the SR-B1 expression at this stage is associated with thecal and interstitial cells, with no signal detected in the granulosa cells. Dramatic changes in SR-B1 expression were seen during follicle maturation induced by PMSG administration. During this period, examination of SR-B1 mRNA expression revealed that the intensity of the signal significantly increased in layers of thecal cells surrounding the follicles. No expression of SR-B1 mRNA was detected in the granulosa cells even after PMSG administration. It is interesting to note that SR-B1 is localized exclusively in thecal and interstitial cells, cell types using cholesterol for conversion to steroids. The absence of the hybridization signal in the granulosa cells is not surprising because the major steroidogenic function of the granulosa cells is to convert androgens to estrogens. The source of cholesterol needed for other functions, such as cell membrane biogenesis, in the granulosa cells is not understood.
As luteinization proceeds, a dramatic shift in the cellular localization of SR-B1 mRNA became apparent. The lutein- ized granulosa cells showed abundant expression of SR-B1 mRNA, as evidenced by the increased intensity of the hybridization signal in the corpus luteum. As the corpora lutea were fully developed after hCG injection, only a few follicles were present in the ovary, and they showed no evidence of the SR-B1 expression. The luteal cells showed bright in situ hybridization signals. As we have shown previously that the binding of acetylated LDL, a ligand for SR-B1, was induced in the luteal cell membrane by the administration of hCG, the possible effect of hormone treatment on the expression of SR-B1 mRNA was examined. Examination of the Northern blots of SR-B1 mRNA revealed that hCG administration increased the expression of SR-B1 mRNA. This is consistent with our previous studies in which we have demonstrated the induction of 125 I-acetylated LDL binding to luteal cell membranes after hCG administration (16) .
These results clearly show that SR-B1 mRNA is expressed in the thecal cells, corpora lutea, and interstitial cells, but not in the granulosa cells, before luteinization. It is interesting to note that the cells expressing SR-B1 are also capable of using cholesterol for steroid hormone biosynthesis. For example, conversion of cholesterol to pregnenolone takes place in all of these cell types, except granulosa cells, which acquire androstenedione and testosterone from the thecal cells which are then converted to estrogens. The relative abundance of SR-B1 mRNA in the thecal cells during folliculogenesis, its increase during the life span of the corpus luteum, and its inducibility by hCG further support the role of SR-B1 in ovarian physiology in a manner consistent with the steroidogenic activity of these cells requiring cholesterol. The mechanism of the interaction of SR-B1 protein present in the ovarian membranes with HDL particles and the mechanism of cholesterol uptake mediated by this protein from cholesterol-laden particles into the ovary require further investigation.
